Hiroaki Mitsuya - Concepedia

Author

Hiroaki Mitsuya

Also Known As

H MITSUYA, H Mitsuya, H. MITSUYA, H. Mitsuya, HIROAKI MITSUYA, Haruna Mitsuya, Hideki Hasegawa, Hiroaki MITSUYA, Hiroaki Mitsuya, L.C. Kovari

792

Publications

33.9K

Citations

H-Index

187

Concepts

All Affiliations

National Cancer Institute Kumamoto University National Institutes of Health National Center for Global Health and Medicine Purdue University West Lafayette

About

Hiroaki Mitsuya is an author at National Cancer Institute specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	188	18.1K
2	Natural Sciences	33	60	5.5K
3	Health Sciences	6	6	269
4	Engineering	2	2	24
5	Public Health	1	1	20

Hiroaki Mitsuya

376

Publications

29.9K

Citations

H-Index

Page 1

	Year	Citations
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Hiroaki Mitsuya, Kent J. Weinhold, P A Furman, Proceedings of the National Academy of Sciences ImmunologyBw A509uCytopathic EffectAntiviral DrugImmunotherapy	1985	1.8K
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. P A Furman, James A. Fyfe, M H St Clair, Proceedings of the National Academy of Sciences Viral ReplicationThymidine AnalogImmunologyMolecular BiologyAntiviral Drug	1986	1.3K
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development Masaki Imai, Kiyoko Iwatsuki‐Horimoto, Masato Hatta, Proceedings of the National Academy of Sciences	2020	1.1K
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. Hiroaki Mitsuya, S Broder Proceedings of the National Academy of Sciences Normal T CellsImmunologyCytopathic EffectAntiviral DrugImmunotherapy	1986	1K
ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX Robert Yarchoan, KentJ. Weinhold, H. Kim Lyerly, The Lancet Htlv-iii/lav ReplicationHuman RetrovirusAn InhibitorImmunologyAntiviral Drug Development	1986	803
Designing CD4 immunoadhesins for AIDS therapy Daniel J. Capon, Steven M. Chamow, Joyce Mordenti, Nature Aids TherapyHuman RetrovirusImmunologyAntiviral ResponseAutoimmunity	1989	616
Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Makoto Matsukura, Kazuo Shinozuka, Gerald Zon, Proceedings of the National Academy of Sciences ImmunologyNuclease-resistant Phosphorothioate AnalogsMolecular BiologyPhosphorothioate AnalogsAntiviral Drug	1987	534
Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4 <sup>+</sup> Cells Hiroaki Mitsuya, David J. Looney, S Kuno, Science ImmunologyImmunodominanceDextran SulfateAntiviral DrugImmune System	1988	460
In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine Robert Yarchoan, Hiroaki Mitsuya, Rose V. Thomas, Science	1989	425
Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III Hiroaki Mitsuya, Mikuláš Popovič, Robert Yarchoan, Science T CellsHuman RetrovirusImmunologyReverse TranscriptasePathology	1984	400

Page 1